Page 54 - Eceptor News Today

MONT-SAINT-GUIBERT, Belgium, April 04, 2023 -- Celyad Oncology , a biotechnology company focused on innovative technologies for chimeric antigen receptor T-cell therapies, received a letter on... | April 4, 2023

Researchers screened the circulating B lymphocyte repertoires of coronavirus disease 2019 convalescents and vaccines using multiplexed antigen panels.

Just as a tight core is a component of good physical fitness for humans, helping to stabilize our bodies, mutations that tightened the core of the SARS-CoV-2 spike protein in new variants may have increased the virus's fitness.

A new study led by Marshall University researchers focuses on a novel mechanism of the body's regulation of salt balance.

DGIST (President: Kook Yang) announced on March 16th that the research team led by Professor Byung-Chang Suh has investigated for the first time the real-time effect of the G-protein cycle, which acts as a switch in our body, on the structural changes in G protein-coupled receptors (GPCRs).

Researchers investigated the feasibility of utilizing a bacterial contractile injection system for programmable protein delivery.

Researchers summarized studies on the association between high-density lipoprotein cholesterol and different types of cancer

NASH Renaissance 2023 Pemvidutide-Potent GLP-1/Glucagon Dual Receptor Agonist for the Treatment of NASH and Obesity Evercore ISI Research... | March 30, 2023

A study published in Cell Reports Medicine describes that COVID-19 vaccines induce strong T cell response in blood cancer patients, irrespective of antibody response and B cell numbers.

A common amino acid, glycine, can deliver a "slow-down" signal to the brain, likely contributing to major depression, anxiety and other mood disorders in some people, scientists at the Wertheim UF Scripps Institute for Biomedical Innovation & Technology have found.